Author:
Tsuji Keisuke,Kaneko Masatomo,Harada Yuki,Fujihara Atsuko,Ueno Kengo,Nakanishi Masaya,Konishi Eiichi,Takamatsu Tetsuro,Horiguchi Go,Teramukai Satoshi,Ito-Ihara Toshiko,Ukimura Osamu
Subject
Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery
Reference30 articles.
1. European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ);Babjuk;Eur Urol,2022
2. Flaig TW, Spiess PE, Abern M, et al. Bladder cancer, version 3.2023, NCCN clinical practice guidelines in oncology (NCCN guidelines). https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf.
3. Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer;Yafi;Urol Oncol,2015
4. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic;Blick;BJU Int,2012
5. Morphologists overestimate the nuclear-to-cytoplasmic ratio;Mingjuan;Cancer Cytopathol,2016
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献